Viral Vector and Plasmid DNA Manufacturing Market CAGR of 22.1%: Latest Industry Research Insights
The biopharmaceutical industry is witnessing unprecedented growth in gene therapies, cell therapies, and advanced vaccine development, creating strong demand for viral vectors and plasmid DNA. These critical components serve as the foundation for genetic medicine manufacturing and play a crucial role in the production of innovative therapeutics. The increasing number of clinical trials...
0 Comments 0 Shares 400 Views 0 Reviews